U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis ...
Study finds annual healthcare costs per patient are significantly higher than previously described– HHT costs are higher than other ...
The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...
A new study published in the journal of BMC Nephrology showed that the effectiveness of roxadustat is comparable at varying ...
Some people naturally have higher levels of proteins that protect them from COVID-19. New studies at Umeå University of our immune system may pave the way for more personalized treatments of both ...
Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...
Crohn’s disease may be a lifelong condition, but today, there are an abundance of effective treatments that can help bring relief to your symptoms and reduce your risk of experiencing more serious ...
AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...
The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...
In 1996, California became the first state to legalize medical marijuana, paving the way for nationwide reform. In the 28 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback